{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:18:46Z","timestamp":1787879926782,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hebei University Graduate Student Innovation Funding Project","award":["CXZZBS2025028"],"award-info":[{"award-number":["CXZZBS2025028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02429-6","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:03:54Z","timestamp":1781618634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiomics using contrast-enhanced T1-weighted imaging and clinical features for predicting response to EGFR-TKIs in EGFR-mutated non-small cell lung cancer patients with brain metastases"],"prefix":"10.1186","volume":"26","author":[{"given":"Lian-Yu","family":"Sui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Ye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hong","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Shuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"1","key":"2429_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","volume":"5","author":"AS Achrol","year":"2019","unstructured":"Achrol AS, Rennert RC, Anders C, et al. Brain metastases[J]. Nat Reviews Disease Primers. 2019;5(1):5.","journal-title":"Nat Reviews Disease Primers"},{"issue":"1","key":"2429_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.14791\/btrt.2023.0049","volume":"12","author":"KS Sung","year":"2024","unstructured":"Sung KS. Clinical Practice Guidelines for Brain Metastasis From Solid Tumors[J]. Brain Tumor Res Treat. 2024;12(1):14\u201322.","journal-title":"Brain Tumor Res Treat"},{"issue":"9","key":"2429_CR3","first-page":"1447","volume":"23","author":"N Lamba","year":"2021","unstructured":"Lamba N, Wen PY, Aizer AA. Epidemiology of brain metastases and leptomeningeal disease[J]. Neurooncology. 2021;23(9):1447\u201356.","journal-title":"Neurooncology"},{"issue":"2","key":"2429_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11060-017-2590-x","volume":"135","author":"M Ge","year":"2017","unstructured":"Ge M, Zhuang Y, Zhou X, et al. High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases[J]. J Neurooncol. 2017;135(2):413\u20138.","journal-title":"J Neurooncol"},{"issue":"9","key":"2429_CR5","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1634\/theoncologist.2017-0557","volume":"23","author":"MJ Khandekar","year":"2018","unstructured":"Khandekar MJ, Piotrowska Z, Willers H, et al. Role of Epidermal Growth Factor Receptor (EGFR) Inhibitors and Radiation in the Management of Brain Metastases from EGFR Mutant Lung Cancers[J]. Oncologist. 2018;23(9):1054\u201362.","journal-title":"Oncologist"},{"issue":"1","key":"2429_CR6","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025[J]. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2429_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41568-019-0220-y","volume":"20","author":"A Boire","year":"2020","unstructured":"Boire A, Brastianos PK, Garzia L, et al. Brain metastasis[J]. Nat Rev Cancer. 2020;20(1):4\u201311.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2429_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41698-024-00575-0","volume":"8","author":"S Khalighi","year":"2024","unstructured":"Khalighi S, Reddy K, Midya A, et al. Artificial intelligence in neuro-oncology: advances and challenges in brain tumor diagnosis, prognosis, and precision treatment[J]. NPJ Precis Oncol. 2024;8(1):80.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"2429_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/jmri.26058","volume":"48","author":"I Dregely","year":"2018","unstructured":"Dregely I, Prezzi D, Kelly-Morland C, et al. Imaging biomarkers in oncology: Basics and application to MRI[J]. J Magn Reson Imaging. 2018;48(1):13\u201326.","journal-title":"J Magn Reson Imaging"},{"issue":"11","key":"2429_CR10","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","volume":"32","author":"E Le Rhun","year":"2021","unstructured":"Le Rhun E, Guckenberger M, Smits M, et al. EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours[J]. Ann Oncol. 2021;32(11):1332\u201347.","journal-title":"Ann Oncol"},{"issue":"1","key":"2429_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11596-022-2535-2","volume":"42","author":"S Ren","year":"2022","unstructured":"Ren S, Tang HJ, Zhao R, et al. Application of Unenhanced Computed Tomography Texture Analysis to Differentiate Pancreatic Adenosquamous Carcinoma from Pancreatic Ductal Adenocarcinoma[J]. Curr Med Sci. 2022;42(1):217\u201325.","journal-title":"Curr Med Sci"},{"issue":"8","key":"2429_CR12","doi-asserted-by":"publisher","first-page":"109373","DOI":"10.4329\/wjr.v17.i8.109373","volume":"17","author":"S Ren","year":"2025","unstructured":"Ren S, Qin B, Daniels MJ, et al. Developing and validating a computed tomography radiomics strategy to predict lymph node metastasis in pancreatic cancer[J]. World J Radiol. 2025;17(8):109373.","journal-title":"World J Radiol"},{"issue":"12","key":"2429_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine[J]. Nat Rev Clin Oncol. 2017;14(12):749\u201362.","journal-title":"Nat Rev Clin Oncol"},{"key":"2429_CR14","doi-asserted-by":"publisher","first-page":"110082","DOI":"10.1016\/j.radonc.2024.110082","volume":"191","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhang G, Qiu X, et al. Non-invasive decision support for clinical treatment of non-small cell lung cancer using a multiscale radiomics approach[J]. Radiother Oncol. 2024;191:110082.","journal-title":"Radiother Oncol"},{"key":"2429_CR15","doi-asserted-by":"publisher","first-page":"101826","DOI":"10.1016\/j.tranon.2023.101826","volume":"39","author":"T-W Wang","year":"2024","unstructured":"Wang T-W, Chao H-S, Chiu H-Y, et al. Radiomics of metastatic brain tumor as a predictive image biomarker of progression-free survival in patients with non-small-cell lung cancer with brain metastasis receiving tyrosine kinase inhibitors[J]. Translational Oncol. 2024;39:101826.","journal-title":"Translational Oncol"},{"issue":"6","key":"2429_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/neuonc\/noaa007","volume":"22","author":"A Mouraviev","year":"2020","unstructured":"Mouraviev A, Detsky J, Sahgal A, et al. Use of radiomics for the prediction of local control of brain metastases after stereotactic radiosurgery[J]. Neuro Oncol. 2020;22(6):797\u2013805.","journal-title":"Neuro Oncol"},{"issue":"6","key":"2429_CR17","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","volume":"16","author":"NU Lin","year":"2015","unstructured":"Lin NU, Lee EQ, Aoyama H, et al. Response assessment criteria for brain metastases: proposal from the RANO group[J]. Lancet Oncol. 2015;16(6):e270\u2013278.","journal-title":"Lancet Oncol"},{"issue":"9","key":"2429_CR18","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1016\/j.acra.2025.05.043","volume":"32","author":"X Xia","year":"2025","unstructured":"Xia X, Qiu J, Tan Q, et al. Radiomics-Based Differentiation of Primary Central Nervous System Lymphoma and Solitary Brain Metastasis Using Contrast-Enhanced T1-Weighted Imaging: A Retrospective Machine Learning Study[J]. Acad Radiol. 2025;32(9):5401\u201312.","journal-title":"Acad Radiol"},{"issue":"9","key":"2429_CR19","doi-asserted-by":"publisher","first-page":"5388","DOI":"10.1016\/j.acra.2025.05.016","volume":"32","author":"X Xia","year":"2025","unstructured":"Xia X, Wu W, Tan Q, et al. Interpretable Machine Learning Models for Differentiating Glioblastoma From Solitary Brain Metastasis Using Radiomics[J]. Acad Radiol. 2025;32(9):5388\u2013400.","journal-title":"Acad Radiol"},{"issue":"2","key":"2429_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/jmri.26643","volume":"50","author":"M Artzi","year":"2019","unstructured":"Artzi M, Bressler I, Ben Bashat D. Differentiation between glioblastoma, brain metastasis and subtypes using radiomics analysis[J]. J Magn Reson Imaging. 2019;50(2):519\u201328.","journal-title":"J Magn Reson Imaging"},{"key":"2429_CR21","first-page":"493","volume":"2017","author":"R Ortiz-Ramon","year":"2017","unstructured":"Ortiz-Ramon R, Larroza A, Arana E, et al. A radiomics evaluation of 2D and 3D MRI texture features to classify brain metastases from lung cancer and melanoma[J]. Annu Int Conf IEEE Eng Med Biol Soc. 2017;2017:493\u20136.","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"issue":"1","key":"2429_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/jmri.28276","volume":"57","author":"LM Zhao","year":"2023","unstructured":"Zhao LM, Hu R, Xie FF, et al. Radiomic-Based MRI for Classification of Solitary Brain Metastases Subtypes From Primary Lymphoma of the Central Nervous System[J]. J Magn Reson Imaging. 2023;57(1):227\u201335.","journal-title":"J Magn Reson Imaging"},{"key":"2429_CR23","doi-asserted-by":"crossref","unstructured":"Kanakarajan H, De Baene W, Sitskoorn M, et al. Predicting local control of brain metastases after stereotactic radiosurgery with clinical, radiomics and deep learning features[J]. medRxiv. 2024:2024.2005.2013.24307241.","DOI":"10.1101\/2024.05.13.24307241"},{"key":"2429_CR24","doi-asserted-by":"crossref","unstructured":"Ressa G, Levi R, Savini G, et al. AI differentiates radionecrosis from true progression in brain metastasis upon stereotactic radiosurgery: analysis of 124 histologically assessed lesions[J]. Neuro Oncol. 2025.","DOI":"10.1093\/neuonc\/noaf090"},{"key":"2429_CR25","doi-asserted-by":"publisher","first-page":"1373330","DOI":"10.3389\/fimmu.2024.1373330","volume":"15","author":"J Xu","year":"2024","unstructured":"Xu J, Wang P, Li Y, et al. Development and validation of an MRI-Based nomogram to predict the effectiveness of immunotherapy for brain metastasis in patients with non-small cell lung cancer[J]. Front Immunol. 2024;15:1373330.","journal-title":"Front Immunol"},{"issue":"11","key":"2429_CR26","doi-asserted-by":"publisher","first-page":"7902","DOI":"10.1007\/s00330-023-09709-7","volume":"33","author":"Y Fan","year":"2023","unstructured":"Fan Y, Wang X, Dong Y, et al. Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC[J]. Eur Radiol. 2023;33(11):7902\u201312.","journal-title":"Eur Radiol"},{"issue":"1","key":"2429_CR27","first-page":"i1","volume":"19","author":"MC Chamberlain","year":"2016","unstructured":"Chamberlain MC, Baik CS, Gadi VK, et al. Systemic therapy of brain metastases: non\u2013small cell lung cancer, breast cancer, and melanoma[J]. Neurooncology. 2016;19(1):i1\u201324.","journal-title":"Neurooncology"},{"issue":"11","key":"2429_CR28","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1093\/neuonc\/noq076","volume":"12","author":"AF Eichler","year":"2010","unstructured":"Eichler AF, Kahle KT, Wang DL, et al. EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer[J]. Neuro Oncol. 2010;12(11):1193\u20139.","journal-title":"Neuro Oncol"},{"issue":"4","key":"2429_CR29","doi-asserted-by":"publisher","first-page":"e582","DOI":"10.1016\/j.crad.2024.01.005","volume":"79","author":"J Qu","year":"2024","unstructured":"Qu J, Zhang T, Zhang X, et al. MRI radiomics for predicting intracranial progression in non-small-cell lung cancer patients with brain metastases treated with epidermal growth factor receptor tyrosine kinase inhibitors[J]. Clin Radiol. 2024;79(4):e582\u201391.","journal-title":"Clin Radiol"},{"key":"2429_CR30","doi-asserted-by":"crossref","unstructured":"Liu L, Teng J, Zhang L, et al. The combination of the tumor markers suggests the histological diagnosis of lung cancer[J]. Biomed Res Int. 2017;2017:2013989.","DOI":"10.1155\/2017\/2013989"},{"issue":"7","key":"2429_CR31","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.crad.2024.02.016","volume":"79","author":"H Qi","year":"2024","unstructured":"Qi H, Hou Y, Zheng Z, et al. MRI radiomics predicts the efficacy of EGFR-TKI in EGFR-mutant non-small-cell lung cancer with brain metastasis[J]. Clin Radiol. 2024;79(7):515\u201325.","journal-title":"Clin Radiol"},{"issue":"1","key":"2429_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12885-024-12121-z","volume":"24","author":"H Qi","year":"2024","unstructured":"Qi H, Hou Y, Zheng Z, et al. Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases[J]. BMC Cancer. 2024;24(1):362.","journal-title":"BMC Cancer"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02429-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02429-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02429-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:55:54Z","timestamp":1787878554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02429-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2429"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02429-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8521529\/v1","asserted-by":"object"}]},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the institutional review board (\u201cEthics committee of the Affiliated Hospital of Hebei University\u201d, Dongfeng Road, No. 212, Lianchi District, Baoding 071000, China, Number HDFYLL-KY-2024-037; date of approval 02\/28\/2024), was conducted in accordance with the Declaration of Helsinki. Informed consent was waived for all patients due to the retrospective nature of this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"431"}}